84
Participants
Start Date
September 27, 2019
Primary Completion Date
May 15, 2023
Study Completion Date
May 15, 2023
Investigational Procedures
The investigational assessments will be performed
Investigational Site Number :0320002, CABA
Investigational Site Number :0560001, Leuven
Investigational Site Number :8400003, The Bronx
Investigational Site Number :8400001, Valhalla
Investigational Site Number :2030001, Prague
Investigational Site Number :7240001, Madrid
Investigational Site Number :8400002, Atlanta
Investigational Site Number :380001, Udine
Investigational Site Number :7920003, Istanbul
Investigational Site Number :2760002, Giessen
Investigational Site Number :7240004, Seville
Investigational Site Number :2500002, Angers
Investigational Site Number :2760005, Mainz
Investigational Site Number :2500003, Paris
Investigational Site Number :380002, Napoli
Investigational Site Number :6420001, Timișoara
Investigational Site Number :152002, Santiago
Investigational Site Number :0320001, Córdoba
Investigational Site Number :0760001, Porto Alegre
Investigational Site Number :0760002, São Paulo
Investigational Site Number :0760006, São Paulo
Investigational Site Number :152001, Santiago
Investigational Site Number :2500001, Paris
Investigational Site Number :7240005, Barcelona
Investigational Site Number :7920001, Izmir
Investigational Site Number :6200001, Porto
Investigational Site Number :6200002, Porto
Investigational Site Number :7920005, Adana
Lead Sponsor
Sanofi
INDUSTRY